Scott McCandless

Columnist, Bloomberg Opinion and Lecturer, Yale School of Management · Person

Mentions

Episodes

Claims

Scott McCandless - Columnist, Bloomberg Opinion and Lecturer, Yale School of Management. Tracked across 9 mentions in podcasts and expert conversations analyzed by Sonic.

What Scott McCandless has said

The CEO of a small healthcare company stated they would pay 10 times the current price for Anthropic's Claude without hesitation.

bullish·Scott McCandless

The first Edison generator plant in New York City initially served approximately 400 light bulbs.

neutral·Scott McCandless

Data centers are projected to account for 60% of the tax revenues in Loudoun County, Virginia.

bullish·Scott McCandless

The CEO of a small healthcare company stated they would pay 10 times the current price for Anthropic's Claude without hesitation.

Expert perspectiveScott McCandlessMay 31

The first Edison generator plant in New York City initially served approximately 400 light bulbs.

Expert perspectiveScott McCandlessMay 31

Data centers are projected to account for 60% of the tax revenues in Loudoun County, Virginia.

Expert perspectiveScott McCandlessMay 31

Scott McCandless suggests that SpaceX's valuation of $1.75 trillion is a sign of a market bubble.

Expert perspectiveScott McCandlessMay 31

According to recent benchmarks, open-weights AI labs from China are only 4 to 8 months behind the leading proprietary models.

Expert perspectiveScott McCandlessMay 31

Warren Buffett famously described the airline industry as a "machine for incinerating capital."

Expert perspectiveScott McCandlessMay 31

Scott McCandless believes that a 4 to 8 month technological lead over open-source competitors from China does not constitute a significant competitive moat for leading AI companies.

Expert perspectiveScott McCandlessMay 31

Despite their significant tax revenue contributions, there is a large public pushback against data center construction in Loudoun County, Virginia.

Expert perspectiveScott McCandlessMay 31

According to research by Gary Pisano at Harvard Business School, the biotech industry was largely unprofitable between 1975 and 2004, possibly making money in only a single year.

Expert perspectiveScott McCandlessMay 31

Create a free account to see Scott McCandless's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Entity Detail